4Sciacca FL, Ciusan JE, Silvani A, et al. Genetic and plasma markers of venous thrombocmbolism in patients with high grade glioma. Clin CancerRes, 2004, 10 (4): 1312-1317.
5Marrasl C, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma : an evidence - based review. Cancer, 2000, 89 (3) 640-646.
6Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): 338-400.
7Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation, 2003, 107(23 Suppl 1): 9-16.
8Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg,2003, 26: 154-158.
9Geerts WH, Heir JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119(1 Suppl): 132-175.
10Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med, 2002, 162: 1833-1840.
